chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient came in for 2nd dose of Moderna Vaccine, after the observation time, per caregiver states as they were in the parking lot the patient mentioned he didn't feel good.  He fell onto the floor and began to have a seizure, the seizure lasted about 2min, patient came to and less than a minute had a second seizure.  Patient was given Atavan 10mg and about 4min later, the patient had a 3rd seizure.  Paramedics were called and he was transported to the ER.
Severe thrombocytopenia (Platelets = 5) and diffuse petechial rash to trunk and extremities
dizzy; sick to his stomach; queasy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), ABDOMINAL DISCOMFORT (sick to his stomach) and NAUSEA (queasy) in a 92-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PANTOPRAZOLE for an unknown indication.    On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced DIZZINESS (dizzy), ABDOMINAL DISCOMFORT (sick to his stomach) and NAUSEA (queasy). At the time of the report, DIZZINESS (dizzy), ABDOMINAL DISCOMFORT (sick to his stomach) and NAUSEA (queasy) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Treatment information was not provided.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-132303 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
admitted to hosp 2 days p/MMR; fever 102-103; cheeks puffed out; MD says reaction to MMR; no to take anymore until tested past age 2;
Information has been received from a physician concerning a 6 year old male who on 21-APR-2004 and 24-APR-2007 was vaccinated with the first and second doses of MMR II (route and lot# not reported). On 08-DEC-2009 the patient experienced mumps. On 10-DEC-2009 the patient was diagnosed with mumps. The parotitis was on the right side. The patient was afebrile. On 10-DEC-2009, a first blood work was performed. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
UKNOWN BRAND OF VACCINE; lightheadedness and arm "heaviness" status post receiving the first COVID vaccine 30 minutes PTA.
admitted with acute on chronic hypercapnic and acute hypoxic respiratory failure in the setting of COVID-19,
This spontaneous report as received from a registered nurse refers to a male patient of unknown age. The patient was vaccinated with, .5 ml M-M-R II on 09nov2012 that expired on 10/26/2012. Lot # 1426Z. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced expired drug administered. No treatment information was reported. The outcome of expired drug administered is unknown. Expired drug administered is not related to M-M-R II. No adverse effects have been observed or reported. No additional information currently available.  Additional information is not expected.
body aches Narrative: EMPLOYEE STATES: "I was out 3 days suffering from side effects of the vaccine- called out of work 5/26, 5/27, and 5/31"
Aches in both arms (mostly in arm that was vaccinated), backache, restlessness, insomnia, headache, overall body fatigue. All of these things caused me to wake up in the middle of the night around 3:30 AM the day after vaccination.
3" erythematous sharply demarcated, warm with 1 cm darker outer.
Abnormal menstrual bleeding (spotting not during menstrual cycle).  I had a similar reaction after my third covid booster (also Pfizer, administered 11/8/2021) that lasted for 6+ months, but I did not report it at the time as I was told by my doctor that it was not related to the covid-19 vaccine.  The fact that my menstrual spotting resolved 6 months after my third covid booster and my periods were totally normal for six months then menstrual spotting began again shortly after getting my 4th covid booster on 1/10/23, I feel like this needs to be reported to VAERS.
Patient received a third dose in error and also was on immunocomprising therapy. The vaccine prescription was under our collaborative practice agreement, but since CDC/ACIP recommendations do not support giving shingrix to patients on immunocompromising therapy, this should not have been given under those circumstances. The combination of immunocompromising therapy and patient receiving a third dose I wanted to report in the event any adverse events do arise.
I had issues for 7 days including, rapid heartbeat, high blood pressure (146/96), facial swelling, random bruising and swelling on my left arm (not by the injection site), rash on face and body (small red dots), dizziness, weakness, nauseous, fatigue, vomiting, injection site pain/tenderness, night sweats.
Began with headache about 9am on 12/24. By 4pm symptoms included chills, sweating, joint pain, muscle pain. From 4pm to 8pm on 12/24 was the worst period of time. Fever never went above 99. Treated with OTC medicines (Tylenol, Motrin) and rest until symptoms subsided on 12/26 at about 5pm.
Left arm was very sore, slightly red and swollen. I also had flu type symptoms like, fever, chills. Lasted for 2-3 days.
Headache, chills, body aches, rapid heartbeat, sore arm  Narrative: employee states; she began experiencing symptoms within the first 24 hours
Patient was in observation room when she complained of "numbness in throat, with trouble swallowing" at approximately 11:30 AM. Patient stated she has a history of anaphylaxis in the past with injectable migraine medication. No SOB, or respiratory issues noted, alert and oriented to person, place, time upon assessment. Notified clinical site lead RN. Epipen brought in by client given and EMS called, taken to ER for further evaluation. Patient stated difficulty with swallowing relieved but numbness continued. Father accompanied patient to ER. VS: 122/64, 96, 100% O2 saturation, 20 respirations.
Joint pain in shoulders, elbows, wrists, hips, knees and ankles starting morning after vaccination. As of 6/09/21, I still have joint pain in my right arm in my elbow and wrist, along with some mild pitting in the fingernails of my right hand.
From initial information received via telephone on 10/21/02, it was reported that a 54 year old female patient had been vaccinated with Fluzone on 10/11/02. The patient developed a red area, 2cm in diameter, with tiny blisters and itching. The patient went to her doctor's office on 10/14/02. No other signs or symptoms reported. It was not reported whether the patient recovered.
Began with slurring of speech.  Progressed to muscular weakness.  Diagnosed as Myasthenia Gravis.
Pain on left shoulder and arm; Pain on left shoulder and arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP), Program ID: (159558). The reporter is the patient.  A 63-year-old female patient received BNT162b2 (BNT162B2), in May2021 as dose 1, single (Batch/Lot number: unknown) at the age of 63 years, in left arm for covid-19 immunisation. The patient's family history included: "blood clotting" (unspecified if ongoing), notes: in the family; "diabetic" (unspecified if ongoing), notes: Mother is diabetic and history of arthritis; "arthritis" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Warfarin for blood clotting; Alopurinol for Gout. Vaccination history included: Tetanus shot (Tetanus arm soreness but it went away and it did not last. Unknown manufacturer, lot and expiration), for Immunization, reaction(s): "soreness". The following information was reported: ARTHRALGIA (non-serious), PAIN IN EXTREMITY (non-serious) all with onset May2021, outcome "not recovered" and all described as "Pain on left shoulder and arm". The events "pain on left shoulder and arm" required emergency room visit. Therapeutic measures were not taken as a result of arthralgia, pain in extremity.  Additional information: The patient was experiencing the pain ever since she got the injection. She thought it was like when you get a tetanus shot, that pain, only it never went away. Patient thought it was another issue with her shoulder than the injection. When she did go back to Urgent Care last week, they looked it up and told her there were other people with similar issues as her and she should notify Pfizer about it. Patient believes 1st dose was in May2021 at 13:30 and 2nd was Jun2021. This pain occurred after the first dose. This would have been the first shot, and then she got the booster like a month afterwards, a month between the two. Patient received a flu and shingles shot but they were way later. No further details provided. Patient did the waiting period they recommend and there was no reaction or soreness which she said was like a Tetanus. Patient stated the previous soreness to the Tetanus shot was nothing like this. She did not have a manufacturer, lot or expiration for the previous Tetanus. It went away, but this pain had not. The patient was normally took Warfarin for blood clotting and Alopurinol for Gout, both prior to getting the vaccine. Patient did not have prior Vaccinations (within 4 weeks) prior to the first administration date of the suspect vaccine.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) :PFIZER INC-202200724940 Same product and event, different patients
approx 15 seconds p/TD/MMR/PPD pt fainted out for 5 sec, pupils dilated & equal, color pale, BP 102/70, P52 irr & weak, pt taken to hosp (pt hit head on floor);
Patient presented to Labor and Delivery triage the morning of March 11th, 2016 with low back pain and extremity pain.  No motor loss or sensory loss.  Return to triage March 14th with same sxms but now with addition of lower ext greater than upper ext weakness with paresthesias. Stat MRI was WNL, EMG by Neurology confirmed Guillain Barre.  Patient had worsening protection of airway.  STAT LTCS done under general anesthesia.  Patient as of today (3/21/2016) remains on ventilation and in ICU, stable.
No additional AE; an office manager informed her of MMRII with a labeled expiry of 5/29/2022 was administered; This spontaneous report was received from an office manager via employee and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 13-JUN-2022, the patient was vaccinated with one dose (quality: 1) of me asles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (therapy type: rHA) subcutaneous injection, 0.5 milliliter for prophylaxis (lot #T018669, expiration date: 29-MAY-2022, strength and route of administration were not provided) (expired product administered). No additional adverse event was reported (no adverse event).  This is the one of six reports received from the same reporter.; Sender's Comments:  US-009507513-2207USA006816: US-009507513-2207USA007049: US-009507513-2207USA007041: US-009507513-2207USA007043: US-009507513-2207USA007052:
All lasted two days: chills, fatigue, body aches, nausea, headache
Patient received flu vaccine in right thigh on 10/25/2016, evaluated in clinic with localized redness (28cm x21cm) and swelling, firm to touch several cms around injection site.
Per mother's report patient developed diarrhea and vomiting within one hour of vaccination. He also developed a temperature of 99.7, was cold and clammy, pale and was complaining of headache. Symptoms resolved within 12 hours. Experienced malaise for at least 24 hours after vaccination. Provider recommended that they push fluids, give TYLENOL as needed and gave ER precautions, also recommended to monitor for new signs or symptoms and that these symptoms should resolve within 24 hours.
Severe developmental regression which led to Autism, and a severe feeding disorder. Patient was healthy and thriving. She always met milestones. Suddenly after her 15 month vaccinations she lost everything she learned. My child was forever changed.
Syncopic event in student vaccinated as part of Meningococcal carriage study in high school gymnasium.  Student was standing, lost consciousness and fell to floor. Remained supine and unresponsive for 5-10 seconds with eyes open. Appeared pale. Alert and oriented upon awakening. Positioned supine with legs elevated and then taken to school nurse's office in wheelchair. Reported nauseous, otherwise no discomfort.  Returned to class after short time in nurse's office.
Pain in arm of injection, unable to raise arm above head, extreme muscle/ligament pain that has not gotten better after 1 month.
patient came in for covid vaccine clinic. got her vaccine and at the 15 min mark, got up to leave and got dizzy for 15 seconds then it resolved. no syncope, cp, sob, HA, or slurred speech. we kept her another 20 minutes to monitor. her son was with her and took her home afterwards without complication. she had not eaten yet today which she postulates as the reason. she has had some water. she is not in any beta blockers. she has no hx of diabetes. bp 130/64, O2 sats 99%, HR 67, RR 16, appears well, pleasant, conversive.
Sore arm; Can't lift up her arm for 3 days; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and MOVEMENT DISORDER (Can't lift up her arm for 3 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001E21A and 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and MOVEMENT DISORDER (Can't lift up her arm for 3 days). On 12-Mar-2021, PAIN IN EXTREMITY (Sore arm) and MOVEMENT DISORDER (Can't lift up her arm for 3 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were reported. No treatment medication was reported.
left arm has a patch of discoloration; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in the left arm on 15Jan2021 at 09:00 (at the age of 33-years-old) as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient was not allergic to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 22Jan2021, the patient's left arm had a patch of discoloration which appeared approximately one week after the vaccination. The patient did not receive treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of "left arm has a patch of discoloration" was unknown.
Hospitalization: 9/28/2022 - 10/1/2022  Presentation to the ED: R ELBOW LACERATION.  COVID-19 + date: 9/28/22. Treatment: NO TREATMENT SPECIFIC FOR COVID. Discharge to: SNF, (Skilled nursing facility).
Suspected Vaccination failure; still got shingles; immune system is terrible; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected Vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: still got shingles) and immune system disorder (Verbatim: immune system is terrible). The outcome of the vaccination failure was unknown and the outcome of the shingles and immune system disorder were not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and immune system disorder to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and immune system disorder to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 18-JUN-2023 The case was received from the consumer interactive digital media. The patient had the Shingles vaccines and still got shingles.  The patient stated that he/she was sitting here with shingles now and his/her immune system was terrible. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
sore arm; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 24Jan2021 13:00 (Lot number: EL3247) at the age of 68 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (ongoing), notes: Onset date : years ago, Stop date: Ongoing; "Fibromyalgia" (ongoing), notes: Onset date : years ago, Stop date: Ongoing; "Hypothyroid" (ongoing), notes: Onset date : years ago, Stop date: Ongoing; "Obesity" (ongoing), notes: Onset date : years ago, Stop date: Ongoing; "Multiple sclerosis" (unspecified if ongoing), notes: Family medical history relevant to ae to sister; "Kidney failure" (unspecified if ongoing), notes: Family medical history relevant to ae to sister; "Stroke" (unspecified if ongoing), notes: Family medical history relevant to ae to mother; "Asthma" (unspecified if ongoing), notes: Family medical history relevant to ae to mother; "Congestive Heart failure" (unspecified if ongoing), notes: Family medical history relevant to ae to father; "Kidney disease" (unspecified if ongoing), notes: Family medical history relevant to ae to father; "Alcoholism" (unspecified if ongoing), notes: Family medical history relevant to ae to father; "Type 2 Diabetes" (unspecified if ongoing), notes: Family medical history relevant to ae to father. Concomitant medication(s) included: DULOXETINE taken for fibromyalgia (ongoing); LEVOTHYROXINE taken for thyroid disorder (ongoing); NALTREXONE taken for fibromyalgia (ongoing); BREO ELLIPTA taken for asthma (ongoing); DEXAMETHAZONE, start date: 29Aug2021; ALBUTEROL [SALBUTAMOL SULFATE] taken for dyspnoea, start date: 29Aug2021; MONOCLONAL, ANTIBODIES taken for covid-19, start date: 01Sep2021. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 24Jan2021, outcome "unknown", described as "sore arm"; FATIGUE (non-serious) with onset 24Jan2021, outcome "unknown", described as "fatigue". Relevant laboratory tests and procedures are available in the appropriate section.  Clinical course: Dose: 2nd :Date: 14Feb2021:Time: 13:00:Site and Route of injection:Anatomical Site of injection: L Arm:Route of administration: Intramuscular Batch/Lot Number: EL9263:On 14Feb2021: Covid Vaccine: Fever, Chills, fatigue, Headache, Nausea (Few hours):27Aug2021: Covid Test: Pos: Fever, Chest Congestion etc. basically every covid symptom except covid es and rash:It took about 3 weeks to recover and over a month to fully recover with lingering Fatigue  No follow-up attempts are possible. No further information is expected.
Itchy watery red eye with headache on left side; Itchy watery red eye with headache on left side; Itchy watery red eye with headache on left side; Itchy watery red eye with headache on left side; This is a spontaneous report from a non-contactable consumer (patient). A 68-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 11Mar2021 at 10:00 AM, (Batch/Lot Number: EN6208) as DOSE 1, SINGLE (at the age of 68-years-old) for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had no known allergies to medications, food, or other products. On 11Mar2021 at 08:00 PM, the patient experienced itchy watery red eye with headache on left side. The events were non serious and did not result in death/Life threatening/Caused/prolonged hospitalization/Disabling/Incapacitating/Congenital anomaly/birth defect. The patient received no treatment for the adverse events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had not recovered from the adverse events.  No follow-up attempts are possible. No further information is expected.
Redness at and around the injection site covering the entire forearm/Redness at and around the injection site; Injection site is also hot to touch; This case was reported by a consumer via call center representative and described the occurrence of erythema of extremities in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26th May 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, 1 week after receiving Shingrix, the patient experienced erythema of extremities and injection site warmth. On an unknown date, the outcome of the erythema of extremities was not recovered/not resolved and the outcome of the injection site warmth was recovered/resolved.   It was unknown if the reporter considered the erythema of extremities and injection site warmth to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the right arm. About a week after vacciantion, the patient experienced redness at and around the injection site covering the entire forearm.  The redness at injection site was also hot to touch.  Hot to touch lasted for 2 days, but the redness was present at the time of reporting. No other details were provided. The reporter consented to follow up.
Patient c/o: dizziness, lightheaded, feels as if she is going to have a panic attack, very fatigued.
it is important to note that I also received the Fluzone high dose bivalent immunization, lot # UJ875AA at the same time as the Moderna bivalent vaccine in the opposite arm a few days, estimate 5, after the injection, i began having very vivid dreams, 18 days later i felt shaky and discovered that my blood pressure dropped to in the low 100 and heartrate into the forties, i was seen by my cardiologist, on September 21, that would have been 3 weeks after the immunization, my heart rate was 43 in his office.  the nebivolol was discontinued and I was started on hydrochlorothiazide,  the blood pressure has been a bit labile, but the heart rate rose into the 70s.  I continue to have very vivid, upsetting dreams which awaken me, about 2-3 times a week.